Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Nanosonics Limited ( (AU:NAN) ) has shared an announcement.
UBS Group AG and its related bodies corporate have notified Nanosonics Limited that they have ceased to be a substantial shareholder in the company as of 8 April 2026. The reduction below the substantial holding threshold signals a notable change in the company’s institutional shareholder base, which may alter the balance of major investors and could influence future trading dynamics and governance considerations for stakeholders.
The most recent analyst rating on (AU:NAN) stock is a Buy with a A$4.50 price target. To see the full list of analyst forecasts on Nanosonics Limited stock, see the AU:NAN Stock Forecast page.
More about Nanosonics Limited
Nanosonics Limited is a medical technology company focused on infection prevention solutions for healthcare settings. The company is best known for its ultrasound probe disinfection systems and related products, targeting hospitals and clinics that require high standards of instrument reprocessing and patient safety.
Average Trading Volume: 756,253
Technical Sentiment Signal: Sell
Current Market Cap: A$1.12B
For detailed information about NAN stock, go to TipRanks’ Stock Analysis page.